IBRX
insider transactionsImmunityBio, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-23.0K
0 buy · 23.0K sell
Net value · 30d
-$165.3K
$0 in · $165.3K out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
1
0 buy · 23.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
65.6K sh
Own New
-
Grant·A
Director
$0
65.6K sh
Own New
-
Grant·A
Director
$0
65.6K sh
Own New
-
Grant·A
Director
$0
65.6K sh
Own New
-
Grant·A
Director
$0
65.6K sh
Own New
-
Grant·A
Director
$0
65.6K sh
Own New
-
Sell·S
Director · 10b5-1
$165.3K
23.0K sh · $7.18
Own -1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | Christobel Selecky | Grant A | 65.6K | $0 |
| Jun 9, 2026 | Linda Maxwell | Grant A | 65.6K | $0 |
| Jun 9, 2026 | Bruce Wendel | Grant A | 65.6K | $0 |
| Jun 9, 2026 | Cheryl Cohen | Grant A | 65.6K | $0 |
| Jun 9, 2026 | Wesley Clark | Grant A | 65.6K | $0 |
| Jun 9, 2026 | Michael D Blaszyk | Grant A | 65.6K | $0 |
| Jun 4, 2026 | Barry J. Simon 10b5-1 | Sell S | 23.0K | $165.3K |
About IBRX insider trading
This page tracks insider transactions for ImmunityBio, Inc. (IBRX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.